newsfilter
← Latest News
Business Wire·

TherapeuticsMD Announces Additional $7 Million Private Placement

Maturity Date of Financing Agreement Extended to November 30, 2022 TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women's healthcare company, announced today that it